Alterations in cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2024
DOI: 10.1152/ajpgi.00091.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2024. Verfasst von Michael Momoh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, United States. Hauptthemen laut MEDLINE: Myosin Type V. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NCI NIH HHS.
Abstract (Originalsprache)
This study demonstrates the importance of MYO5B for cellular lipid metabolism and mitochondria in intestinal epithelial cells, previously unexplored functions of MYO5B. The alterations may underlie the progenitor cell malfunction observed in microvillus inclusion disease (MVID) intestines. To examine the therapeutic potential of progenitor-targeted treatments, the effects of the LPAR5-preferred agonist Compound-1 were investigated utilizing several MVID model mice and enteroids. Our observations suggest that Compound-1 may provide a therapeutic approach for treating MVID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
- Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, United States.
- Nashville VA Medical Center, Nashville, Tennessee, United States.
ORCID-Profile: Michael Momoh, Sudiksha Rathan-Kumar, Monica E Brown, James R Goldenring, Izumi Kaji
Förderung
- NIDDK NIH HHS
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NCI NIH HHS
- Volpe Foundation
- HHS | NIH | National Cancer Institute
Zitieren
APA
Momoh, M., Rathan-Kumar, S., Burman, A., Brown, M. E., Adeniran, F., Ramos, C., Goldenring, J. R., Roland, J. T., & Kaji, I. (2024). Alterations in cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00091.2024
Vancouver
Momoh M, Rathan-Kumar S, Burman A, Brown ME, Adeniran F, Ramos C, et al. Alterations in cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024. doi:10.1152/ajpgi.00091.2024
BibTeX
@article{Momoh2024,
author = {Momoh, Michael and Rathan-Kumar, Sudiksha and Burman, Andreanna and Brown, Monica E and Adeniran, Francisca and Ramos, Cynthia and Goldenring, James R and Roland, Joseph T and Kaji, Izumi},
title = {Alterations in cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2024},
doi = {10.1152/ajpgi.00091.2024}
}
EUVIMED